T1	Disease 2355 2372	Colorectal cancer
T2	Disease 2374 2377	CRC
*	Equiv T1 T2
T3	DiseaseTreatment 16 65	neoadjuvant chemoradiotherapy with 5-fluorouracil
T4	FactorValue 1186 1200	non-responders
T5	FactorValue 1202 1204	NR
*	Equiv T4 T5
T6	FactorValue 1207 1225	partial responders
T7	FactorValue 1227 1229	PR
*	Equiv T6 T7
T8	FactorValue 1235 1251	total responders
T9	FactorValue 1253 1255	TR
*	Equiv T8 T9
T10	NumberOfSamples 1112 1124	twenty-three
T11	PrecursorMassTolerance 17438 17443	7 ppm
T12	FragmentMassTolerance 17467 17473	20 ppm
T13	Instrument 15895 15931	OrbiTrap QExactive mass spectrometer
T14	IonizationType 15970 15979	EasySpray
T15	Separation 15463 15499	Dionex Ultimate 3000 nanoHPLC system
T16	FragmentationMethod 16328 16358	collision induced dissociation
T17	CollisionEnergy 16388 16391	35%
T18	NumberOfMissedCleavages 17190 17191	2
T19	Modification 17237 17269	carbamidomethylation on cysteine
A1	Modification T19 fixed
T21	Modification 17363 17383	methionine oxidation
A2	Modification T21 variable
T22	Modification 17388 17418	protein N-terminal acetylation
A3	Modification T22 variable
T23	Organism 17087 17099	Homo sapiens
T25	OrganismPart 3016 3022	rectum
T24	AlkylationReagent 12934 12947	iodoacetamide
T26	ReductionReagent 12875 12889	dithiothreitol
T27	CleavageAgent 14064 14076	Trypsin Gold
